Home LiteratureArticle Details
PMID: 759664 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.

On the diagnosis and treatment of breast cancer.

JAMA ·Vol. 241 ·No. 5 ·1979-02-02 ·Pages 489-94

Fox MS

Abstract

Randomized trials comparing surgical treatments of breast cancer show that radical mastectomy offers no greater benefit than simple mastectomy followed by radiotherapy. Furthermore, in terms of survival, radical mastectomy seems to be no better than wide excision followed by radiotherapy when the disease is clinically diagnosed as stage 1. The incidence of diagnosed breast cancer showed an 18% increase between 1935 and 1965 and a 50% increase between 1965 and 1975. However, breast cancer mortality has remained unchanged for at least the past 40 years. Analysis of survival curves of women with breast cancer suggests that two or more populations exist, with about 40% suffering fatal outcome unaffected by treatment. The remaining 60% exhibit a relative mortality only modestly different from that of women of similar ages without evidence of disease. Increasing detection of an entity that is histologically defined as malignant but biologically relatively benign could account for the observed increase in incidence.

MeSH Terms
Breast Neoplasms/diagnosis,mortality,radiotherapy,surgery Female Humans Mastectomy/methods Neoplasm Metastasis Postoperative Care Risk Time Factors
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Fox M S
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1979-02-02
Pages
489-94
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com